Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseWoundCD-1Malen = n = 6 wounds per group harvested at each time point on days…Topical application of the hydrogel precursor onto the wound followed by photocrosslinking with visible light for 4 minutesHydrogels loaded with 5.0% (w/w) nanoparticles to gelatin m…Applied on day 0 immediately after the wounds were created
Model: Bilateral 6 mm full-thickness excisional dorsal skin wounds created with a biopsy punch and immobilised with sutured silicone splints
In vitro the miR-223 mimic hydrogel raised the Arg1/iNOS2 ratio about sevenfold at 24 h and reduced TNF-alpha, IL-6 and IL-1beta in M1-induced macrophages. In vivo a single application gave 95.8% wound closure by day 12 versus 66.7% for negative control miRNA, 60.8% for plain hydrogel and 44.9% for…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.